News

Published on 11 Jan 2024 on Zacks via Yahoo Finance

5 Small-Cap Stocks to Play the January Effect


Article preview image

Wall Street had a disappointing start to 2024 as the nine-week winning streak snapped, erasing some of the strong gains seen at the end of 2023. Overstretched valuations and uncertainty around when the Fed will begin to cut rates have dampened investors’ optimism. The decline was broad-based, with small-cap stocks plunging the most.The Russell 2000 Index declined 3.7% in the initial week of 2024. The trend might reverse, given what is called the “January Effect," which refers to a seasonal increase in stock prices during the month of January. This phenomenon is often observed in the stock market, where, historically, stock prices have shown a tendency to rise more in January than in other months.For investors looking to capitalize on this opportunity, small-cap stocks that are down in double digits in the initial week of 2024, have a solid Zacks Rank #1 (Strong Buy) or #2 (Buy) and a Momentum Score of B or more seem solid choices. These include Anavex Life Sciences AVXL, Peakstone Realty Trust PKST, AC Immune SA ACIU, Getaround, Inc. GETR, and Akoya Biosciences Inc. AKYA.

Is January Effect a Myth or Reality?

According to some market experts, the January Effect actually runs from mid-December through February, with small-caps continuing to outperform their large-cap cousins.While the start of 2024 has seen some deviation from the expected January Effect, the year-end tax considerations, and investment of year-end bonuses will push the stock market higher in the first month of the year. Investors also redeploy their capital to speculate on weaker performers in January after selling winners in December to create tax losses. Further, the start of a new year often brings renewed optimism among investors, leading to increased buying activity.Over the long term, small-cap stocks have generally shown stronger performance in January compared to large-cap stocks. However, this trend is not consistent every year, and there have been several years where the January Effect was minimal or absent. It has become less pronounced in recent years due to changes in tax laws and the increased use of tax-advantaged retirement accounts.

NASDAQ.ACIU price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
New Strong Buy Stocks for January 31st

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: EnerSys (ENS): This ener...

Zacks · via Yahoo Finance 1 Feb 2025

High Growth Tech Stocks in the United States

Over the last 7 days, the United States market has dropped 2.6%, yet it has risen by 24% over the...

Simply Wall St. · via Yahoo Finance 2 Jan 2025

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

AC Immune (ACIU) announced positive interim safety and immunogenicity data from the Phase 2 VacSY...

TipRanks · via Yahoo Finance 16 Nov 2024

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

AC Immune SA (NASDAQ:ACIU) is set to release its Q3 2024 earnings on Oct 24, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 23 Oct 2024

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's...

Key Insights AC Immune to hold its Annual General Meeting on 20th of JuneSalary of CHF578.0k is p...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

AC Immune SA (NASDAQ:ACIU) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control...

Key Insights The considerable ownership by private equity firms in AC Immune indicates that they ...

Simply Wall St. via Yahoo Finance 24 May 2024

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

AC Immune SA (NASDAQ:ACIU) shareholders should be happy to see the share price up 17% in the last...

Simply Wall St. via Yahoo Finance 15 Mar 2024

5 Small-Cap Stocks to Play the January Effect

Wall Street had a disappointing start to 2024 as the nine-week winning streak snapped, erasing so...

Zacks via Yahoo Finance 11 Jan 2024

AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held...

Key Insights Significant control over AC Immune by private equity firms implies that the general ...

Simply Wall St. via Yahoo Finance 13 Dec 2023